News | May 19, 2022
WHO validates Convidecia vaccine for Covid-19
The vaccine was found to have 64% efficacy against symptomatic disease and 92% against severe Covid-19
The vaccine was found to have 64% efficacy against symptomatic disease and 92% against severe Covid-19
New Covid-19 Medriva Rapid Antigen Test kits with very high- sensitivity now available in Australia
The meeting was co-organized by World Health Organization’s Country Office for India, World Animal Protection India and ReAct Asia Pacific
It would be the first protein-based alternative available in Israel
Novavax' vaccine has received authorizations of the vaccine in over 170 countries
All the recommendations have been sent to the Drugs Controller General of India (DCGI) for final approval.
GCC Biotech is manufacturing the kits on a public-private partnership (PPP) model
Following the review of around 20 candidate vaccines by the external advisory group, MVC's vaccine was selected as one of two to be included in the global trial
The WHO chief scientist Soumya Swaminathan tweeted on Oct. 17
Bharat Biotech has been submitting data to the WHO on a rolling basis and submitted additional information at WHO’s request on September 27th 2021
Subscribe To Our Newsletter & Stay Updated
